Day One Biopharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $29,208 | $93,761 | $8,192 | $0 |
Gross Profit | 26,226 | 92,171 | 7,485 | -116 |
EBITDA | -64,573 | 29,636 | -114,494 | -66,767 |
EBIT | -65,332 | -114,902 | -66,883 | |
Net Income | -65,714 | 37,037 | -4,407 | -62,412 |
Net Change In Cash | 29,208 | 93,761 | 8,192 | 0 |
Free Cash Flow | -31,427 | -4,971 | -66,255 | -49,729 |
Cash | 124,968 | 422,765 | 239,616 | 270,391 |
Basic Shares | 93,623 | 96,937 | 87,121 | 86,679 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $131,161 | $0 | $0 | $0 |
Gross Profit | 125,882 | -383 | -531 | -199 |
EBITDA | -217,270 | -206,064 | -146,378 | -72,544 |
EBIT | -206,447 | -146,909 | -72,743 | |
Net Income | -95,496 | -188,917 | -132,176 | -70,442 |
Net Change In Cash | 131,161 | 0 | 0 | 0 |
Cost of Revenue | -199,047 | 240,581 | ||
Free Cash Flow | -80,282 | -150,077 | -109,900 | -56,539 |
Cash | 124,968 | 230,784 | 85,262 | 284,309 |
Basic Shares | 93,623 | 79,773 | 65,466 | 61,952 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.63 |
2024-09-30 | $0.38 |
2024-06-30 | -$0.05 |
2024-03-31 | -$0.72 |
